000 | 01184 a2200337 4500 | ||
---|---|---|---|
005 | 20250512205224.0 | ||
264 | 0 | _c19830317 | |
008 | 198303s 0 0 eng d | ||
022 | _a0014-9446 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDollery, C T | |
245 | 0 | 0 |
_aHypertension and new antihypertensive drugs: clinical perspectives. _h[electronic resource] |
260 |
_bFederation proceedings _cFeb 1983 |
||
300 |
_a207-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAngiotensin-Converting Enzyme Inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 | _aCoronary Circulation |
650 | 0 | 4 | _aDinoprostone |
650 | 0 | 4 | _aDopamine Antagonists |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEpoprostenol _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aProstaglandins E _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
650 | 0 | 4 |
_aSympathetic Nervous System _xdrug effects |
773 | 0 |
_tFederation proceedings _gvol. 42 _gno. 2 _gp. 207-10 |
|
999 |
_c6295748 _d6295748 |